Skip to main content

Table 5 Masaoka-Koga stage of thymoma and TSCC according to thymic cortical and medullary markers expression

From: The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma

markers

Masaoka-Koga stage

Pa

I

II

III

IV

β5t

    

+

15(55.6)

7(25.9)

4(14.8)

1(3.7)

0.020

-

6(24.0)

10(40.0)

9(36.0)

0

 

PRSS16

    

+

11(39.3)

12(42.9)

4(14.3)

1(3.6)

0.862

-

10(41.7)

5(20.8)

9(37.5)

0

Cathepsin V

    

+

11(37.9)

11(37.9)

6(20.7)

1(3.4)

0.686

-

10(43.5)

6(26.1)

7(30.4)

0

CD40

     

+

16(53.3)

7(23.3)

7(23.3)

0

0.026

-

5(22.7)

10(45.5)

6(27.3)

1(4.5)

 

Claudin-4

     

+

11(39.3)

8(28.6)

9(32.1)

0

0.862

-

10(41.7)

9(37.5)

4(16.7)

1(4.2)

 

AIRE

     

+

14(48.3)

8(27.6)

7(24.1)

0

0.193

-

7(30.4)

9(39.1)

6(26.1)

1(4.3)

 
  1. aI vs. II, III, IV